Trials / Completed
CompletedNCT00332293
AL-15469A for the Treatment of Bacterial Conjunctivitis
An Evaluation of the Safety and Efficacy of Moxifloxacin AF Ophthalmic Solution 0.5% for the Treatment of Bacterial Conjunctivitis in India
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 695 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 1 Month
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin Alternative Formulation Ophthalmic Solution 0.5% | 1 drop into the conjunctival sac of both eyes 3 times a day for 3 days |
| DRUG | Moxifloxacin hydrochloride ophthalmic solution 0.5% as base | 1 drop into the conjunctival sac of both eyes 3 times a day for 3 days |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2006-12-01
- Completion
- 2006-12-01
- First posted
- 2006-06-01
- Last updated
- 2016-11-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00332293. Inclusion in this directory is not an endorsement.